| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.007 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.097 | 0.007 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.097 | 0.007 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.17 | 0.008 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.008 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.009 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.43 | 0.01 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.01 |